Keeley Funds Comments on Cigna Corp

Guru stock highlight

Author's Avatar
Apr 18, 2019

Cigna Corporation (CI - $160.82 – NYSE) (NYSE:CI) is a global health insurer that in 2018 acquired pharmacy bene t manager Express Scripts. Investors initially were not fans of the deal, but later came around. In the rst quarter, however, shares were pressured after investors began questioning whether Cigna can execute on the deal’s integration.

Investors also started to worry about potential changes to rebate practices for PBMs and proposals from Democratic Presidential candidates and Congressmen for “Medicare for All”. While we acknowledge that changes may come to the way healthcare is paid for in the US, we believe Cigna and the other managed care companies will be part of the solution.

From Keeley Funds' first-quarter 2019 Keeley Mid-Cap Dividend Value Fund commentary.